Information Collection: Medical Use of Byproduct Material, 84835-84836 [2023-26718]
Download as PDF
Federal Register / Vol. 88, No. 233 / Wednesday, December 6, 2023 / Notices
The NEA
is particularly interested in comments
which:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
SUPPLEMENTARY INFORMATION:
Dated: November 30, 2023.
RaShaunda Thomas,
Deputy Director, Office of Administrative
Services & Contracts, National Endowment
for the Arts.
Rockville, Maryland.
Dated: November 30, 2023.
Edward R. Hawkens,
Chief Administrative Judge, Atomic Safety
and Licensing Board Panel.
[FR Doc. 2023–26715 Filed 12–5–23; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[NRC–2023–0065]
[FR Doc. 2023–26710 Filed 12–5–23; 8:45 am]
BILLING CODE 7537–01–P
Information Collection: Medical Use of
Byproduct Material
NUCLEAR REGULATORY
COMMISSION
AGENCY:
[Docket Nos. 50–250–SLR–2 and 50–251–
SLR–2; ASLBP No. 24–981–01–SLR–BD01]
Florida Power & Light Company;
Establishment of Atomic Safety and
Licensing Board
Florida Power & Light Company
(Turkey Point Nuclear Generating Units
3 and 4)
This proceeding involves the twentyyear subsequent license renewal of
Renewed Facility Operating Licenses
DPR–31 and DPR–41, which currently
authorize Florida Power & Light
Company to operate Turkey Point
Nuclear Generating Units 3 and 4 until,
respectively, July 19, 2032 and April 10,
2033. In response to a notice published
in the Federal Register, see 88 FR 62110
(Sept. 8, 2023), Miami Waterkeeper filed
a hearing request.
VerDate Sep<11>2014
20:52 Dec 05, 2023
Jkt 262001
Nuclear Regulatory
Commission.
ACTION: Notice of submission to the
Office of Management and Budget;
request for comment.
The U.S. Nuclear Regulatory
Commission (NRC) has recently
submitted a request for renewal of an
existing collection of information to the
Office of Management and Budget
(OMB) for review. The information
collection is entitled ‘‘Medical Use of
Byproduct Material.’’
DATES: Submit comments by January 5,
2024. Comments received after this date
will be considered if it is practical to do
so, but the Commission is able to ensure
consideration only for comments
received on or before this date.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to https://www.reginfo.gov/
public/do/PRAMain. Find this
particular information collection by
selecting ‘‘Currently under Review—
Open for Public Comments’’ or by using
the search function.
FOR FURTHER INFORMATION CONTACT:
David C. Cullison, NRC Clearance
Officer, U.S. Nuclear Regulatory
SUMMARY:
Pursuant to delegation by the
Commission, see 37 FR 28710 (Dec. 29,
1972), and the Commission’s
regulations, see, e.g., 10 CFR 2.104,
2.105, 2.300, 2.309, 2.313, 2.318, 2.321,
notice is hereby given that an Atomic
Safety and Licensing Board (Board) is
being established to preside over the
following proceeding:
lotter on DSK11XQN23PROD with NOTICES1
The Board is comprised of the
following Administrative Judges:
Emily I. Krause, Chair, Atomic Safety
and Licensing Board Panel, U.S.
Nuclear Regulatory Commission,
Washington, DC 20555–0001
Dr. Sue H. Abreu, Atomic Safety and
Licensing Board Panel, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001
Dr. Michael F. Kennedy, Atomic Safety
and Licensing Board Panel, U.S.
Nuclear Regulatory Commission,
Washington, DC 20555–0001
All correspondence, documents, and
other materials shall be filed in
accordance with the NRC E-Filing rule.
See 10 CFR 2.302.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
84835
Commission, Washington, DC 20555–
0001; telephone: 301–415–2084; email:
Infocollects.Resource@nrc.gov.
SUPPLEMENTARY INFORMATION:
I. Obtaining Information and
Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC–2023–
0065 when contacting the NRC about
the availability of information for this
action. You may obtain publicly
available information related to this
action by any of the following methods:
• Federal Rulemaking Website: Go to
https://www.regulations.gov and search
for Docket ID NRC–2023–0065.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publicly
available documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘Begin Web-based ADAMS Search.’’ For
problems with ADAMS, please contact
the NRC’s Public Document Room (PDR)
reference staff at 1–800–397–4209, at
301–415–4737, or by email to
PDR.Resource@nrc.gov. The supporting
statement and burden spreadsheet are
available in ADAMS under Accession
Nos. ML23284A132 and ML23284A131.
• NRC’s PDR: The PDR, where you
may examine and order copies of
publicly available documents, is open
by appointment. To make an
appointment to visit the PDR, please
send an email to PDR.Resource@nrc.gov
or call 1–800–397–4209 or 301–415–
4737, between 8 a.m. and 4 p.m. eastern
time (ET), Monday through Friday,
except Federal holidays.
• NRC’s Clearance Officer: A copy of
the collection of information and related
instructions may be obtained without
charge by contacting the NRC’s
Clearance Officer, David C. Cullison,
Office of the Chief Information Officer,
U.S. Nuclear Regulatory Commission,
Washington, DC 20555–0001; telephone:
301–415–2084; email:
Infocollects.Resource@nrc.gov.
B. Submitting Comments
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to https://www.reginfo.gov/
public/do/PRAMain. Find this
particular information collection by
selecting ‘‘Currently under Review—
Open for Public Comments’’ or by using
the search function.
The NRC cautions you not to include
identifying or contact information in
comment submissions that you do not
E:\FR\FM\06DEN1.SGM
06DEN1
84836
Federal Register / Vol. 88, No. 233 / Wednesday, December 6, 2023 / Notices
lotter on DSK11XQN23PROD with NOTICES1
want to be publicly disclosed in your
comment submission. All comment
submissions are posted at https://
www.regulations.gov and entered into
ADAMS. Comment submissions are not
routinely edited to remove identifying
or contact information.
If you are requesting or aggregating
comments from other persons for
submission to the OMB, then you
should inform those persons not to
include identifying or contact
information that they do not want to be
publicly disclosed in their comment
submission. Your request should state
that comment submissions are not
routinely edited to remove such
information before making the comment
submissions available to the public or
entering the comment into ADAMS.
II. Background
Under the provisions of the
Paperwork Reduction Act of 1995 (44
U.S.C. chapter 35), the NRC recently
submitted a request for renewal of an
existing collection of information to
OMB for review entitled, 10 CFR part 35
‘‘Medical Use of Byproduct Material.’’
The NRC hereby informs potential
respondents that an agency may not
conduct or sponsor, and that a person is
not required to respond to, a collection
of information unless it displays a
currently valid OMB control number.
The NRC published a Federal
Register notice with a 60-day comment
period on this information collection on
August 1, 2023, 88 FR 50182.
1. The title of the information
collection: 10 CFR part 35, Medical Use
of Byproduct Material.
2. OMB approval number: 3150–0010.
3. Type of submission: Extension.
4. The form number, if applicable:
Not applicable.
5. How often the collection is required
or requested: Reports of medical events,
doses to an embryo/fetus or nursing
child, or leaking source are reportable
on occurrence. A specialty board
certifying entity desiring to be
recognized by the NRC must submit a
one-time request for recognition and
infrequently revise the information.
6. Who will be required or asked to
respond: Physicians and medical
institutions holding an NRC license
authorizing the administration of
byproduct material or radiation from
this material to humans for medical use.
A specialty board certification entity
desiring to have its certifying process
and board certificate recognized by
NRC.
7. The estimated number of annual
responses: 313,994 (234,284 reporting
responses + 7,327 recordkeepers +
72,383 third party disclosure responses).
VerDate Sep<11>2014
20:52 Dec 05, 2023
Jkt 262001
8. The estimated number of annual
respondents: 7,340 (862 NRC licensees +
6,465 Agreement State licensees + 13
specialty board certification entity).
9. The estimated number of hours
needed annually to comply with the
information collection requirement or
request: 1,117,570 hours (61,807
reporting + 1,043,235 recordkeeping +
12,528 third party disclosure).
10. Abstract: Part 35 of title 10 of the
Code of Federal Regulations, ‘‘Medical
Use of Byproduct Material,’’ contains
NRC’s requirements and provisions for
the medical use of byproduct material
and for issuance of specific licenses
authorizing the medical use of this
material. These requirements and
provisions provide for the radiation
safety of workers, the general public,
patients, and human research subjects.
Part 35 contains mandatory
requirements that apply to NRC
licensees authorized to administer
byproduct material or radiation to
humans for medical use. These
requirements also provide voluntary
provisions for specialty boards to apply
to have their certification processes
recognized by the NRC so that their
board-certified individuals can use the
certifications as proof of training and
experience.
Dated: November 30, 2023.
For the Nuclear Regulatory Commission.
David C. Cullison,
NRC Clearance Officer, Office of the Chief
Information Officer.
[FR Doc. 2023–26718 Filed 12–5–23; 8:45 am]
BILLING CODE 7590–01–P
OFFICE OF PERSONNEL
MANAGEMENT
Submission for Review: Initial
Certification of Full-Time School
Attendance, RI 25–41
Office of Personnel
Management.
ACTION: 30-Day notice and request for
comments.
AGENCY:
The Office of Personnel
Management (OPM), Retirement
Services, offers the general public and
other Federal agencies the opportunity
to comment on the following expiring
information collection (ICR), without
change: Initial Certification of Full-Time
School Attendance, RI 25–41. OPM uses
RI 25–41 to determine if a child is
eligible to receive survivor benefits.
DATES: Comments are encouraged and
will be accepted until January 5, 2024.
ADDRESSES: Written comments and
recommendations for the proposed
SUMMARY:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
information collection should be sent
within 30 days of publication of this
notice to https://www.reginfo.gov/
public/do/PRAMain. Find this
particular information collection by
selecting ‘‘Currently under Review—
Open for Public Comments’’ or by using
the search function or fax to (202) 395–
6974.
FOR FURTHER INFORMATION CONTACT: A
copy of this information collection, with
applicable supporting documentation,
may be obtained by contacting the
Retirement Services Publications Team,
Office of Personnel Management, 1900 E
Street NW, Room 3316–L, Washington,
DC 20415, Attention: Cyrus S. Benson,
or sent via electronic mail to
Cyrus.Benson@opm.gov or faxed to
(202) 606–0910 or via telephone at (202)
936–0401.
SUPPLEMENTARY INFORMATION: As
required by the Paperwork Reduction
Act of 1995, OPM is soliciting
comments for this collection (OMB No.
3206–0099). This information collection
was previously published in the Federal
Register on May 3, 2023, at 88 FR
27929, allowing for a 60-day public
comment period. No comments were
received for this collection. The purpose
of this notice is to allow an additional
30 days for public comments. OPM is
particularly interested in comments
that:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
RI 25–41, Initial Certification of FullTime School Attendance is used to
determine whether a child is unmarried
and a full-time student in a recognized
school. OPM must determine this in
order to pay survivor annuity benefits to
children who are age 18 or older under
5 U.S.C. 8341(A)(4) and chapter 84,
section 8441(4)(C).
E:\FR\FM\06DEN1.SGM
06DEN1
Agencies
[Federal Register Volume 88, Number 233 (Wednesday, December 6, 2023)]
[Notices]
[Pages 84835-84836]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-26718]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[NRC-2023-0065]
Information Collection: Medical Use of Byproduct Material
AGENCY: Nuclear Regulatory Commission.
ACTION: Notice of submission to the Office of Management and Budget;
request for comment.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has recently
submitted a request for renewal of an existing collection of
information to the Office of Management and Budget (OMB) for review.
The information collection is entitled ``Medical Use of Byproduct
Material.''
DATES: Submit comments by January 5, 2024. Comments received after this
date will be considered if it is practical to do so, but the Commission
is able to ensure consideration only for comments received on or before
this date.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to https://www.reginfo.gov/public/do/PRAMain. Find this
particular information collection by selecting ``Currently under
Review--Open for Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: David C. Cullison, NRC Clearance
Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001;
telephone: 301-415-2084; email: [email protected].
SUPPLEMENTARY INFORMATION:
I. Obtaining Information and Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC-2023-0065 when contacting the NRC
about the availability of information for this action. You may obtain
publicly available information related to this action by any of the
following methods:
Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2023-0065.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly available documents online in the
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin Web-based ADAMS
Search.'' For problems with ADAMS, please contact the NRC's Public
Document Room (PDR) reference staff at 1-800-397-4209, at 301-415-4737,
or by email to [email protected]. The supporting statement and
burden spreadsheet are available in ADAMS under Accession Nos.
ML23284A132 and ML23284A131.
NRC's PDR: The PDR, where you may examine and order copies
of publicly available documents, is open by appointment. To make an
appointment to visit the PDR, please send an email to
[email protected] or call 1-800-397-4209 or 301-415-4737, between 8
a.m. and 4 p.m. eastern time (ET), Monday through Friday, except
Federal holidays.
NRC's Clearance Officer: A copy of the collection of
information and related instructions may be obtained without charge by
contacting the NRC's Clearance Officer, David C. Cullison, Office of
the Chief Information Officer, U.S. Nuclear Regulatory Commission,
Washington, DC 20555-0001; telephone: 301-415-2084; email:
[email protected].
B. Submitting Comments
Written comments and recommendations for the proposed information
collection should be sent within 30 days of publication of this notice
to https://www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under Review--Open for
Public Comments'' or by using the search function.
The NRC cautions you not to include identifying or contact
information in comment submissions that you do not
[[Page 84836]]
want to be publicly disclosed in your comment submission. All comment
submissions are posted at https://www.regulations.gov and entered into
ADAMS. Comment submissions are not routinely edited to remove
identifying or contact information.
If you are requesting or aggregating comments from other persons
for submission to the OMB, then you should inform those persons not to
include identifying or contact information that they do not want to be
publicly disclosed in their comment submission. Your request should
state that comment submissions are not routinely edited to remove such
information before making the comment submissions available to the
public or entering the comment into ADAMS.
II. Background
Under the provisions of the Paperwork Reduction Act of 1995 (44
U.S.C. chapter 35), the NRC recently submitted a request for renewal of
an existing collection of information to OMB for review entitled, 10
CFR part 35 ``Medical Use of Byproduct Material.'' The NRC hereby
informs potential respondents that an agency may not conduct or
sponsor, and that a person is not required to respond to, a collection
of information unless it displays a currently valid OMB control number.
The NRC published a Federal Register notice with a 60-day comment
period on this information collection on August 1, 2023, 88 FR 50182.
1. The title of the information collection: 10 CFR part 35, Medical
Use of Byproduct Material.
2. OMB approval number: 3150-0010.
3. Type of submission: Extension.
4. The form number, if applicable: Not applicable.
5. How often the collection is required or requested: Reports of
medical events, doses to an embryo/fetus or nursing child, or leaking
source are reportable on occurrence. A specialty board certifying
entity desiring to be recognized by the NRC must submit a one-time
request for recognition and infrequently revise the information.
6. Who will be required or asked to respond: Physicians and medical
institutions holding an NRC license authorizing the administration of
byproduct material or radiation from this material to humans for
medical use. A specialty board certification entity desiring to have
its certifying process and board certificate recognized by NRC.
7. The estimated number of annual responses: 313,994 (234,284
reporting responses + 7,327 recordkeepers + 72,383 third party
disclosure responses).
8. The estimated number of annual respondents: 7,340 (862 NRC
licensees + 6,465 Agreement State licensees + 13 specialty board
certification entity).
9. The estimated number of hours needed annually to comply with the
information collection requirement or request: 1,117,570 hours (61,807
reporting + 1,043,235 recordkeeping + 12,528 third party disclosure).
10. Abstract: Part 35 of title 10 of the Code of Federal
Regulations, ``Medical Use of Byproduct Material,'' contains NRC's
requirements and provisions for the medical use of byproduct material
and for issuance of specific licenses authorizing the medical use of
this material. These requirements and provisions provide for the
radiation safety of workers, the general public, patients, and human
research subjects. Part 35 contains mandatory requirements that apply
to NRC licensees authorized to administer byproduct material or
radiation to humans for medical use. These requirements also provide
voluntary provisions for specialty boards to apply to have their
certification processes recognized by the NRC so that their board-
certified individuals can use the certifications as proof of training
and experience.
Dated: November 30, 2023.
For the Nuclear Regulatory Commission.
David C. Cullison,
NRC Clearance Officer, Office of the Chief Information Officer.
[FR Doc. 2023-26718 Filed 12-5-23; 8:45 am]
BILLING CODE 7590-01-P